Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Journal of Biopharmaceutical Statistics
|
July 24, 2019
Sample size computation in phase II designs combining the A'Hern design and the Sargent and Goldberg design
Anouk Neven, Murielle Mauer, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 14, 2024
PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients
Antonin Levy, Thierry Berghmans, Michael Koller, et al.
Frontiers in Oncology
|
February 22, 2020
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
Elizabeth Smyth, Maren Knödler, Anne Giraut, et al.
The Lancet. Oncology
|
August 22, 2009
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
Chantal Quinten, Corneel Coens, Murielle Mauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study
Gertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.
The Lancet. Oncology
|
December 5, 2019
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
Justyna Mierzynska, Claire Piccinin, Madeline Pe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2010
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, et al.
Journal of Geriatric Oncology
|
March 23, 2019
Cancer events in Belgian nursing home residents: An EORTC prospective cohort study
Hans Wildiers, Murielle Mauer, Monique Elseviers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 24, 2019
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer
Anna D Wagner, Florian Lordick, Heike I Grabsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article
Hans Wildiers, Murielle Mauer, Athanasios Pallis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Journal of Biopharmaceutical Statistics
|
July 24, 2019
Sample size computation in phase II designs combining the A'Hern design and the Sargent and Goldberg design
Anouk Neven, Murielle Mauer, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 14, 2024
PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients
Antonin Levy, Thierry Berghmans, Michael Koller, et al.
Frontiers in Oncology
|
February 22, 2020
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
Elizabeth Smyth, Maren Knödler, Anne Giraut, et al.
The Lancet. Oncology
|
August 22, 2009
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
Chantal Quinten, Corneel Coens, Murielle Mauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study
Gertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.
The Lancet. Oncology
|
December 5, 2019
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
Justyna Mierzynska, Claire Piccinin, Madeline Pe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2010
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, et al.
Journal of Geriatric Oncology
|
March 23, 2019
Cancer events in Belgian nursing home residents: An EORTC prospective cohort study
Hans Wildiers, Murielle Mauer, Monique Elseviers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 24, 2019
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer
Anna D Wagner, Florian Lordick, Heike I Grabsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2013
End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article
Hans Wildiers, Murielle Mauer, Athanasios Pallis, et al.
Page
of 3